A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea

Trial Profile

A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2017

At a glance

  • Drugs Minocycline (Primary)
  • Indications Rosacea
  • Focus Therapeutic Use
  • Acronyms MARS
  • Sponsors Hovione
  • Most Recent Events

    • 13 Dec 2017 Status changed from not yet recruiting to recruiting, according to a Hovione media release.
    • 13 Dec 2017 According to a Hovione media release, this study will also include a cohort to determine minocycline systemic pharmacokinetic parameters, and completion of this study expected by the end of 2018.
    • 13 Dec 2017 According to a Hovione media release, first patient has been enrolled.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top